{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:05:04Z","timestamp":1790665504222,"version":"4.1.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We recently reported a truncating deletion in the NFKBIE gene, which encodes I\u03baB\u03b5, a negative feedback regulator of NF-\u03baB, in clinically aggressive chronic lymphocytic leukemia (CLL). Because preliminary data indicate enrichment of NFKBIE aberrations in other lymphoid malignancies, we screened a large patient cohort (n = 1460) diagnosed with different lymphoid neoplasms. While NFKBIE deletions were infrequent in follicular lymphoma, splenic marginal zone lymphoma, and T-cell acute lymphoblastic leukemia (&amp;lt;2%), slightly higher frequencies were seen in diffuse large B-cell lymphoma, mantle cell lymphoma, and primary central nervous system lymphoma (3% to 4%). In contrast, a remarkably high frequency of NFKBIE aberrations (46\/203 cases [22.7%]) was observed in primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (3\/11 cases [27.3%]). NFKBIE-deleted PMBL patients were more often therapy refractory (P = .022) and displayed inferior outcome compared with wild-type patients (5-year survival, 59% vs 78%; P = .034); however, they appeared to benefit from radiotherapy (P = .022) and rituximab-containing regimens (P = .074). NFKBIE aberrations remained an independent factor in multivariate analysis (P = .003) and when restricting the analysis to immunochemotherapy-treated patients (P = .008). Whole-exome sequencing and gene expression profiling verified the importance of NF-\u03baB deregulation in PMBL. In summary, we identify NFKBIE aberrations as a common genetic event across B-cell malignancies and highlight NFKBIE deletions as a novel poor-prognostic marker in PMBL.<\/jats:p>","DOI":"10.1182\/blood-2016-03-704528","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T03:48:24Z","timestamp":1474948104000},"page":"2666-2670","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma"],"prefix":"10.1182","volume":"128","author":[{"given":"Larry","family":"Mansouri","sequence":"first","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Noerenberg","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mylonas","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaa","family":"Abdulla","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Frick","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazila","family":"Asmar","sequence":"additional","affiliation":[{"name":"Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Ljungstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schneider","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology (Cancer Research), Faculty of Medicine, University of Duisburg-Essen, Essen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Skaftason","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pandzic","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tasidou","sequence":"additional","affiliation":[{"name":"Hematopathology Department, Evangelismos Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Waldhueter","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Rivas-Delgado","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Angelopoulou","sequence":"additional","affiliation":[{"name":"Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Ziepert","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics, and Epidemiology, University at Leipzig, Leipzig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Maximilian","family":"Arends","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Couronn\u00e9","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Adulte, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Necker, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dido","family":"Lenze","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Baldus","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bastard","sequence":"additional","affiliation":[{"name":"INSERM U918, Universit\u00e9 de Rouen, Centre Henri Becquerel, Rouen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Okosun","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Fitzgibbon","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"D\u00f6rken","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans G.","family":"Drexler","sequence":"additional","affiliation":[{"name":"Leibniz-Institute DSMZ\u2013German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Sud, Orsay, France;"},{"name":"INSERM, U1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens A.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga D.","family":"Munch-Petersen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[{"name":"Departments of Molecular Therapy in Haematology and Oncology and Translational Oncology, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany;"},{"name":"Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany;"},{"name":"German Consortium for Translational Cancer Research, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[{"name":"Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Enblad","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Sud, Orsay, France;"},{"name":"INSERM, U1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ralfkiaer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Erlanson","sequence":"additional","affiliation":[{"name":"Department of Radiation Sciences, Oncology, Ume\u00e5 University, Ume\u00e5, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Korkolopoulou","sequence":"additional","affiliation":[{"name":"Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Hultdin","sequence":"additional","affiliation":[{"name":"Department of Medical Biosciences, Pathology, Ume\u00e5 University, Ume\u00e5, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Papadaki","sequence":"additional","affiliation":[{"name":"Hematopathology Department, Evangelismos Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[{"name":"Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lopez-Guillermo","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology (Cancer Research), Faculty of Medicine, University of Duisburg-Essen, Essen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"},{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Stavroyianni","sequence":"additional","affiliation":[{"name":"Hematology Department and Hematopoietic Cell Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kanellis","sequence":"additional","affiliation":[{"name":"Hematopathology Department, Evangelismos Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"},{"name":"Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Marie","family":"Amini","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;"},{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"additional","affiliation":[{"name":"Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9, University Medical Center, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Damm","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Tumor Immunology, Charit\u00e9, University Medical Center, Berlin, Germany;"},{"name":"Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5870","key":"2020071613493233700_B1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"7247","key":"2020071613493233700_B2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"2","key":"2020071613493233700_B3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"2020071613493233700_B4","doi-asserted-by":"crossref","first-page":"a000109","DOI":"10.1101\/cshperspect.a000109","article-title":"Oncogenic activation of NF-kappaB","volume":"2","author":"Staudt","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"2020071613493233700_B5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov"},{"issue":"6","key":"2020071613493233700_B6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.20142009","article-title":"Functional loss of I\u03baB\u03b5 leads to NF-\u03baB deregulation in aggressive chronic lymphocytic leukemia","volume":"212","author":"Mansouri","year":"2015","journal-title":"J Exp Med"},{"issue":"8","key":"2020071613493233700_B7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2015-10-674572","article-title":"Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations","volume":"127","author":"Ljungstr\u00f6m","year":"2016","journal-title":"Blood"},{"key":"2020071613493233700_B8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcancer.2016.07.005","article-title":"NF-\u03baB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions","volume":"39","author":"Mansouri","year":"2016","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"2020071613493233700_B9","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.4049\/jimmunol.1302351","article-title":"I\u03baB\u03b5 is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner","volume":"192","author":"Alves","year":"2014","journal-title":"J Immunol"},{"issue":"3","key":"2020071613493233700_B10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/gcc.22328","article-title":"Whole exome sequencing of relapsed\/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma","volume":"55","author":"Mareschal","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"2020071613493233700_B11","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2020071613493233700_B12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1634\/theoncologist.2011-0275","article-title":"Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care","volume":"17","author":"Vassilakopoulos","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"2020071613493233700_B13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/leu.2015.120","article-title":"PET\/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: an analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy","volume":"30","author":"Vassilakopoulos","year":"2016","journal-title":"Leukemia"},{"issue":"18","key":"2020071613493233700_B14","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2020071613493233700_B15","article-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"18","key":"2020071613493233700_B16","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders","volume":"122","author":"Damm","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2020071613493233700_B17","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","article-title":"Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes","volume":"119","author":"Damm","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2020071613493233700_B18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"2020071613493233700_B19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"3","key":"2020071613493233700_B20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/path.1454","article-title":"Inactivating I kappa B epsilon mutations in Hodgkin\/Reed-Sternberg cells","volume":"201","author":"Emmerich","year":"2003","journal-title":"J Pathol"},{"issue":"1","key":"2020071613493233700_B21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"issue":"15","key":"2020071613493233700_B22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2020071613493233700_B23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"issue":"12","key":"2020071613493233700_B24","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2020071613493233700_B25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/23\/2666\/1396741\/blood704528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/23\/2666\/1396741\/blood704528.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:44:26Z","timestamp":1594946666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/23\/2666\/35651\/Frequent-NFKBIE-deletions-are-associated-with-poor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":25,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-03-704528","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}